Results 251 to 260 of about 156,781 (298)

Bacterial Profile and Antibiotic Susceptibility Patterns of Urogenital Isolates Among Women With Preterm Labor at a Tertiary Hospital in Southwestern Uganda. [PDF]

Cureus
Birungi W, Turanzomwe S, Byamukama O, Bawakanya S, Orishaba F, Kabanda T, Kayondo M, Ngonzi J, Kajabwangu R.   +8 more
europepmc   +1 more source

Fabrication and characterization of an activated carbon-chitosan-graphene oxide hybrid membrane with hierarchical porosity for the simultaneous adsorptive removal of ciprofloxacin antibiotic and hazardous heavy metals from polluted water systems. [PDF]

RSC Adv
El-Shalakany HH, Samir I, Mubarak MF.
europepmc   +1 more source

Correction: In vitro dissolution and release kinetics of multisource ciprofloxacin 500 mg tablets in West Gondar, Ethiopia: Implications for interchangeability and regulatory oversight. [PDF]

PLoS One
Haile TD, Ashenef A, Demeke CA, Anagaw YK, Mekonen AW, Worku MC, Berihun AM, Mekasha YT, Feleke MG.   +8 more
europepmc   +1 more source

Ciprofloxacin

Drug Intelligence & Clinical Pharmacy, 1987
Ciprofloxacin is a new fluorinated quinolone antibiotic with high activity against a wide spectrum of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, Enterobacteriaceae, and Pseudomonas aeruginosa. Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide ...
D K, Terp, M J, Rybak
openaire   +3 more sources

Ciprofloxacin Crystal Nephropathy

American Journal of Kidney Diseases, 2007
Ciprofloxacin is a widely used fluoroquinolone for the treatment of patients with complicated and uncomplicated infections. With rare exceptions, only immune-mediated interstitial nephritis was described, with direct renal damage reported only in case of overdose.
STRATTA, Piero, Lazzarich E, Canavese C, BOZZOLA, Cristina, MONGA, Guido   +4 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of ciprofloxacin

Infection, 1988
The fluorination of piperazinyl substituted quinolones has led to an interesting development of a series of new broad spectrum antibacterial agents that may be administered orally as well as parenterally and are well tolerated. Norfloxacin was an early compound, later followed by ciprofloxacin, enoxacin, ofloxacin and pefloxacin.
T, Bergan, A, Dalhoff, R, Rohwedder
openaire   +2 more sources

Intraperitoneal penetration of ciprofloxacin

European Journal of Clinical Microbiology, 1986
Ciprofloxacin, a quinolone derivative of carboxylic acid, has a spectrum of antimicrobial activity that includes the Enterobacteriaceae, Staphylococcus aureus and Pseudomonas aeruginosa (1). It may therefore prove useful, alone or in combination, in the prophylaxis or treatment of infections in patients undergoing abdominal surgery. Intraperitoneal and
M R, Lockley, R, Waldron, R, Wise, I A, Donovan   +3 more
openaire   +2 more sources

CIPROFLOXACIN AND ANTACIDS

The Lancet, 1986
L C, Preheim, T A, Cuevas, J S, Roccaforte, M A, Mellencamp, M J, Bittner   +4 more
openaire   +4 more sources

CIPROFLOXACIN RESISTANCE

The Lancet, 1987
B, Salh, A K, Webb
openaire   +2 more sources

RESISTANCE TO CIPROFLOXACIN

The Lancet, 1985
S T, Chapman, D C, Speller, D S, Reeves
openaire   +2 more sources